Second-generation antidepressants for preventing seasonal affective disorder

Gerald Gartlehner, Barbara Nussbaumer, Bradley N. Gaynes, Catherine A. Forneris, Laura C. Morgan, Angela Kaminski-Hartenthaler, Amy Greenblatt, Jörg Wipplinger, Linda J. Lux, Jeffrey H. Sonis, Julia Hofmann, Megan G. Van Noord, Dietmar Winkler

Research output: Contribution to journalArticle

14 Scopus citations


This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of SGAs to prevent SAD and improve patient-centred outcomes in adults with a history of SAD.

Original languageEnglish (US)
Article numberCD011268
JournalCochrane Database of Systematic Reviews
Issue number9
StatePublished - Sep 2 2014
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Second-generation antidepressants for preventing seasonal affective disorder'. Together they form a unique fingerprint.

  • Cite this

    Gartlehner, G., Nussbaumer, B., Gaynes, B. N., Forneris, C. A., Morgan, L. C., Kaminski-Hartenthaler, A., Greenblatt, A., Wipplinger, J., Lux, L. J., Sonis, J. H., Hofmann, J., Van Noord, M. G., & Winkler, D. (2014). Second-generation antidepressants for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews, 2014(9), [CD011268].